Disclosed herein is a method of using colchicine. In one embodiment, the method comprises administering to a patient colchicine and a substrate of cytochrome P450 1A2 and monitoring the patient during administration of colchicine and the substrate for an adverse event. Also disclosed are articles of manufacture comprising a container containing a dosage form of colchicine and a method of manufacturing a colchicine product.

 
Web www.patentalert.com

< Dermatological compositions

> OLIGONUCLEOTIDES COMPRISING A NON-PHOSPHATE BACKBONE LINKAGE

> Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof

~ 00569